Keeping a close eye on implants that are opened and not used is one way OR leaders can track practices that add significantly to costs. But what about blood products? Blood taken to the OR and not used also can be costly.
For me, the answer is easy. For 25 years I…
Reforming instrument reprocessing practices does not always end with the…
When it comes to the adoption of artificial intelligence (AI)…